You have found 85 entries after clicking the GO button or a search link in a hot topic. Sorted by the main topic addressed, the list shows in orange the type of entry, year the original document was published (or if one of our own documents, the year last updated), and the type of file you will download when you click on the title. In blue is the document’s title followed by a brief description.
Click blue titles to view full text in a new window
Use the selectors at the bottom to turn to the next page in the list of documents
Re-order the list by the most recently added or updated entries or by the most recently published documents
If you have not found what you want you could: Select from the full range of topics and search options available on our topic search page.
Instead try a free text search for documents which contain the words you specify.
Or try browsing back issues of the magazine or the more recent email bulletins.
Try the information services provided by partner agencies.
Tried everything? E-mail the Findings editor for help by clicking on this logo
Based on research, financial data and stakeholder surveys and testimonies, the UK government’s official drug policy advisers warn that without significant efforts to protect investment and quality, in England “loss of funding will result in the dismantling of a drug misuse treatment system that has brought huge improvement to the lives of people with drug and alcohol problems”.
MATRIX CELL 2020 HTM file
Drug Treatment Matrix cell E3: Treatment systems; Medical treatment
Seminal and key studies relating to local, regional and national systems for effectively and cost-effectively providing medical interventions and treatment in medical settings. Highlights a simple innovation which transformed detoxification recyclers into typical patients, asks if you agree with an expert group’s vision of what a good quality service looks like, and questions whether Britain is making progress on organising care for mentally ill problem drug users.
MATRIX CELL 2018 HTM file
Drug Treatment Matrix cell E2: Treatment systems; Generic and cross-cutting issues
Seminal and key studies on local, regional and national systems for effectively and cost-effectively providing drug addiction treatment. Commentary focuses on payment-by-results funding mechanisms, crime-reduction as a justification for treatment, and ways to improve treatment systems, especially the core care planning process.
MATRIX CELL 2020 HTM file
Alcohol Treatment Matrix cell E4: Treatment systems; Psychosocial therapies
Key studies on systems for effectively and cost-effectively providing psychosocial therapies, and the roles of those therapies within the overall treatment system. Focus is on examining the research credentials of guidance from NICE and mutual aid’s potential to bridge the gap between diminished resources and heightened recovery ambitions.
MATRIX CELL 2018 HTM file
Drug Treatment Matrix cell D3: Organisational functioning; Medical treatment
Seminal and key studies on how treatment organisations affect the implementation and effectiveness of medical interventions and treatment in medical settings. Focus is on UK and US understandings of what counts as a ‘recovery-oriented’ service and on US, Australian and Canadian studies which discovered and validated elements of these visions even before they were articulated.
HOT TOPIC 2016 HTM file
Harm reduction: what’s it for?
‘Hot topics’ offer background and analysis on important issues which sometimes generate heated debate. Opposing agendas have led to a shifting balance between seeing harm-reduction as acceptable only in the service of the greater good of reducing or eliminating drug use, versus seeing it as the overriding objective, one which should never be sacrificed to an anti-drugs agenda.
STUDY 2018 HTM file
Effectiveness of inpatient withdrawal and residential rehabilitation interventions for alcohol use disorder: A national observational, cohort study in England
On the important national indicator of completing treatment and not returning for treatment in the following six months, inpatient and residential treatments for alcohol use disorders in England appeared to be effective half the time. Longer duration of treatment and ongoing care were associated with a greater likelihood of successfully completing treatment.
DOCUMENT 2012 HTM file
Has methadone been rehabilitated?
Arousing visceral opposition and passionate defence, prescribing opiate-type drugs for as long as needed has for decades been the mainstay of heroin addiction treatment in Britain. With the weight of government behind them, that position was challenged by ‘recovery’ advocates; in 2012 an expert report sought to reconcile the competing perspectives.
STUDY 2011 HTM file
A good quality of life under the influence of methadone: a qualitative study among opiate-dependent individuals
Opiate dependent methadone patients in Belgium give their own accounts of what for them constitutes a good quality of life. Generally they want what other people want: a meaningful, independent life and supportive relationships. Methadone creates the preconditions for such a life at the same time as it limits its achievement.
DOCUMENT 2012 HTM file
Medications in recovery: re-orientating drug dependence treatment
On behalf of the UK government an expert group has developed and documented a clinical consensus on how prescribing-based treatment for heroin addiction can be made more recovery-oriented in line with national strategy. Their report will be the main reference point in tussles over what recovery means for methadone services and patients.
Select search results page